[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336378-105":59,"doc-detail-336378-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","screening-of-co-expressed-genes-in-hypopharyngeal-carcinoma-with-esophageal-carcinoma-based-on-rna-sequencing","Screening of co-expressed genes in hypopharyngeal carcinoma with esophageal carcinoma based on RNA sequencing","","Screening of co-expressed genes in hypopharyngeal carcinoma with co-morbid esophageal carcinoma is investigated using RNA sequencing and clinical research methods. Tumor tissues from 6 patients with hypopharyngeal squamous cell carcinoma plus esophageal squamous cell carcinoma (group A) and 6 patients with pure hypopharyngeal squamous cell carcinoma (group B) were sequenced. Bioinformatics analyses identified co-disease hub genes, and ROC curves plus a Nomogram prediction model assessed diagnostic value. Among 44,876 genes, 76 differed significantly between groups. Top hub genes (GABRG2, CACNA1A, CNTNAP2, NOS1, SCN4B) showed high diagnostic performance, suggesting potential molecular markers for risk assessment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/screening-of-co-expressed-genes-in-hypopharyngeal-carcinoma-with-esophageal-carcinoma-based-on-rna-sequencing/336378/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/screening-of-co-expressed-genes-in-hypopharyngeal-carcinoma-with-esophageal-carcinoma-based-on-rna-sequencing/336378.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were the study groups defined?","Question",{"text":112,"@type":113},"The study used two groups: group A included patients with hypopharyngeal squamous cell carcinoma combined with esophageal squamous cell carcinoma, and group B included patients with pure hypopharyngeal squamous cell carcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What sequencing and analysis approach was used to identify hub co-morbidity genes?",{"text":117,"@type":113},"RNA sequencing was performed on tumor tissues, followed by bioinformatics analysis to explore mechanisms and identify hub genes associated with disease development and progression.",{"name":119,"@type":110,"acceptedAnswer":120},"Which hub genes showed high diagnostic value and how was it evaluated?",{"text":121,"@type":113},"GABRG2, CNTNAP2, and SCN4B demonstrated high diagnostic value for determining whether hypopharyngeal carcinoma patients have combined esophageal carcinoma, evaluated using AUC values from ROC analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336378,1790154780,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nScreening of co‑expressed genes in hypopharyngeal carcinoma with esophageal carcinoma based on RNA sequencing and Clinical Research  \nJianing Zhang1,2, Liangyu Zou1,2, Fuxian Tan1, Hongmin Wang1, Zhenlei Wen1, Hongmei Wang1 & Lianhe Li1*  \nTo explore the hub comorbidity genes and potential pathogenic mechanisms of hypopharyngeal carcinoma with esophageal carcinoma, and evaluate their diagnostic value for hypopharyngeal carcinoma with co‑morbid esophageal carcinoma. We performed gene sequencing on tumor tissues from 6 patients with hypopharyngeal squamous cell carcinoma with esophageal squamous cell carcinoma (hereafter referred to as “group A”) and 6 patients with pure hypopharyngeal squamous cell carcinoma (hereafter referred to as “group B”). We analyzed the mechanism of hub genes in the development and progression of hypopharyngeal squamous cell carcinoma with esophageal squamous cell carcinoma through bioinformatics, and constructed an ROC curve and Nomogram prediction model to analyze the value of hub genes in clinical diagnosis and treatment. 44,876 genes were sequenced in 6 patients with group A and 6 patients with group B. Among them, 76 genes showed significant statistical differences between the group A and the group B.47 genes were expressed lower in the group Athan inthe group B, and 29 genes were expressed higher. The top five hub genes were GABRG2, CACNA1A, CNTNAP2, NOS1, and SCN4B. GABRG2, CNTNAP2, and SCN4Bin the hub genes have high diagnostic value in determining whether hypopharyngeal carcinoma patients have combined esophageal carcinoma (AUC: 0.944, 0.944, 0.972). These genes could possibly be used as potential molecular markers for assessing the risk of co‑morbidity of hypopharyngeal carcinoma combined with esophageal carcinoma.  \nKeywords Bioinformatics analysis, Hypopharyngeal squamous cell carcinoma combined with esophageal squamous cell carcinoma, Nomogram, ROC curve, RNA sequencing  \nAbbreviations  \nHPSCCSPM  \nGO  \nKEGG  \nPPI  \nBP  \nCC  \nMF GAPDHAUC  \nGABA GABRG2  \nGABAARCNTNAP2  \nHypopharyngeal squamous cell carcinoma  \nSecond primary malignancies  \nGene ontology  \nKyoto encyclopedia of genes and genomes  \nProtein–Protein interaction  \nBiological processes  \nCellular components  \nMolecular functions  \nGlyceraldehyde-3-phosphate dehydrogenase  \nArea under curve  \nγ-Aminobutyric acid  \nGamma-Aminobutyric acid type A receptor subunit Gamma2 γ-Aminobutyric acid type A receptor  \nContactin Associated Protein 2  \n1Department of Otorhinolaryngology Head and Neck Surgery, Central Hospital of Chaoyang, Liaoning 122000, China. 2These authors contributed equally: Jianing Zhang and Liangyu Zou. * email: [llh186@163.com](llh186@163.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nVGSC Voltage-gated sodium channel  \nSCN4B Sodium voltage-gated channel beta subunit 4 CACNA1A Calcium voltage-gated channel subunit Alpha1 A  \nThe HPSCC (hypopharyngeal squamous cell carcinoma) is one of the head and neck tumors with high malignancy. Its incidence rate is about 3–5% 1 in head and neck malignancies. Research shows that the prognosis of hypopharyngeal carcinoma is poor, with a recurrence median survival period of 6–7 months and a 5-year recurrence-free survival rate of 30–40%2. The Second Primary Malignancy (SPM) is an independent prognostic factor affecting the survival rate of hypopharyngeal carcinoma, significantly increasing the risk of death inpatients with nasopharyngeal carcinoma3. The esophagus is the most common site ofSPMs in patients with head and neck squamous cell carcinoma, with an incidence rate of up to 30% and a risk of 28.6 times higher than that of the normal population4.  \nHypopharyngeal-esophageal carcinomas have no obvious symptoms at the early stage of the disease, because of the special anatomical position of the region, electronic gastroscopy often passes through this region quickly to re","cbCaitCvMMWgmNwY","https://ap.wps.com/l/cbCaitCvMMWgmNwY","pdf",3371511,17,"English","# Methods\n## Experimental materials","[{\"question\":\"How were the study groups defined?\",\"answer\":\"The study used two groups: group A included patients with hypopharyngeal squamous cell carcinoma combined with esophageal squamous cell carcinoma, and group B included patients with pure hypopharyngeal squamous cell carcinoma.\"},{\"question\":\"What sequencing and analysis approach was used to identify hub co-morbidity genes?\",\"answer\":\"RNA sequencing was performed on tumor tissues, followed by bioinformatics analysis to explore mechanisms and identify hub genes associated with disease development and progression.\"},{\"question\":\"Which hub genes showed high diagnostic value and how was it evaluated?\",\"answer\":\"GABRG2, CNTNAP2, and SCN4B demonstrated high diagnostic value for determining whether hypopharyngeal carcinoma patients have combined esophageal carcinoma, evaluated using AUC values from ROC analysis.\"}]","Screening of co-expressed genes in hypopharyngeal carcinoma with esophageal carcinoma based on RNA sequencing | PDF",1790014782,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6111b6646de3ca08c880f03bb6bb1b10.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/385231629b90ca2538e2caf1433df508.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1dba713811ca6188aa955d5a219af24.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b38aa2ef6ce61e67bf5fb7c0277b9d0.webp",980,1287]